发明名称 |
Treatment of membrane bound transcription factor peptidase, site 1 (MBTPS1) related diseases by inhibition of natural antisense transcript to MBTPS1 |
摘要 |
The present invention relates to antisense oligonuclotides that modulate the expression of and/or function of Membrane Bound Transcription Factor Peptidase, site 1 (MBTPS1), in particular, by targeting natural antisense polynucleotides of Membrane Bound Transcription Factor Peptidase, site 1 (MBTPS1). The invention also relates to the identification of these antisense oligonucleotides and their use in treating diseases and disorders associated with the expression of MBTPS1. |
申请公布号 |
US9173895(B2) |
申请公布日期 |
2015.11.03 |
申请号 |
US201013516097 |
申请日期 |
2010.12.15 |
申请人 |
CuRNA, Inc. |
发明人 |
Collard Joseph;Khorkova Sherman Olga |
分类号 |
C12N15/113;A61K31/7088 |
主分类号 |
C12N15/113 |
代理机构 |
CuRNA, Inc. |
代理人 |
CuRNA, Inc. ;Browder Monte R. |
主权项 |
1. A method of upregulating a function of and/or the expression of a Membrane Bound Transcription Factor Peptidase, site 1 (MBTPS1) poly in patient cells or tissues in vivo or in vitro comprising:
contacting said cells or tissues with at least one antisense oligonucleotide 15 to 30 nucleotides in length wherein said at least one oligonucleotide is specific for and specifically hybridizes to a natural antisense polynucleotide of the MBTPS1 gene and has at least 80% sequence identity to a reverse complement of a polynucleotide comprising 15 to 30 nucleotides within nucleotides 1 to 1240 of SEQ ID NO: 2; thereby upregulating a function of and/or the expression of the Membrane Bound Transcription Factor Peptidase, site 1 (MBTPS1) polynucleotide in patient cells or tissues in vivo or in vitro. |
地址 |
Miami FL US |